Literature DB >> 29312775

Case report: improvement of cardiac remodeling with shock wave therapy of a patient with ischemic cardiomyopathy.

Yingnan Bai1, Xiaoyan Wang1, Xin Deng1, Hongyi Wu1, Abdel Hamid Fathy2, Yan Xi1, Yunzeng Zou1, Jie Cui1, Junbo Ge1.   

Abstract

Percutaneous coronary intervention (PCI) and coronary-artery bypass grafting (CABG) are two major preferred reperfusion strategies to restore the ischemic-related artery patency, but PCI and CABG do not necessarily guarantee the recovery of post-procedure left ventricular (LV) dysfunction and release of symptoms. Moreover, there is no definitive effective way to enhance microcirculations. Theoretically, shock wave therapy (SWT) is an option. We report here a case of patient who received SWT. The patient's medical history was characterized by chest pain for 20 years, having received CABG 13 years ago. The follow-up angiography showed all blood vessels are stiff and rigid therefore no chance for a second CABG. After cardiac SWT treatment for 1 year, the patient's symptoms of chest pain and chronic heart failure significantly improved, the odds of cardiac muscle survival increased, the cardiac remodeling was also improved. What's more, left ventricular ejection fraction (LVEF) was improved from 34% to 51% and 43% in half year and 1 year after SWT which is indicated by single-photon emission computed tomography (SPECT), respectively. To our knowledge, this is the first report of 2-cycle cardiac SWT treatments over 1 year with a complete follow-up, indicating that SWT can not only improve the symptoms of chronic heart failure, but also improve LVEF and cardiac remodeling caused by ischemic cardiomyopathy.

Entities:  

Keywords:  Cardiac shock wave therapy (CSWT); angiogenesis; cardiac remodeling; chronic heart failure; microcirculation

Year:  2017        PMID: 29312775      PMCID: PMC5756951          DOI: 10.21037/jtd.2017.11.108

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  18 in total

1.  Impact of coronary microvascular function on long-term cardiac mortality in patients with acute ST-segment-elevation myocardial infarction.

Authors:  Tim P van de Hoef; Matthijs Bax; Martijn Meuwissen; Peter Damman; Ronak Delewi; Robbert J de Winter; Karel T Koch; Carl Schotborgh; José P S Henriques; Jan G P Tijssen; Jan J Piek
Journal:  Circ Cardiovasc Interv       Date:  2013-06-04       Impact factor: 6.546

Review 2.  Coronary microvascular dysfunction, microvascular angina, and treatment strategies.

Authors:  Mark A Marinescu; Adrián I Löffler; Michelle Ouellette; Lavone Smith; Christopher M Kramer; Jamieson M Bourque
Journal:  JACC Cardiovasc Imaging       Date:  2015-02

3.  Effect of cardiac shock wave therapy on the microvolt T wave alternans of patients with coronary artery disease.

Authors:  Ling Zhao; Ping Yang; Yaming Tang; Ruijie Li; Yunzhu Peng; Yu Wang; Lijin Pu; Tao Guo
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Randomized and double-blind controlled clinical trial of extracorporeal cardiac shock wave therapy for coronary heart disease.

Authors:  Ping Yang; Tao Guo; Wei Wang; Yun-Zhu Peng; Yu Wang; Ping Zhou; Zhi-Ling Luo; Hong-Yan Cai; Ling Zhao; Hong-Wen Yang
Journal:  Heart Vessels       Date:  2012-03-30       Impact factor: 2.037

5.  Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction.

Authors:  B L Gerber; C E Rochitte; J A Melin; E R McVeigh; D A Bluemke; K C Wu; L C Becker; J A Lima
Journal:  Circulation       Date:  2000-06-13       Impact factor: 29.690

6.  Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo.

Authors:  Takahiro Nishida; Hiroaki Shimokawa; Keiji Oi; Hideki Tatewaki; Toyokazu Uwatoku; Kohtaro Abe; Yasuharu Matsumoto; Noriyoshi Kajihara; Masataka Eto; Takehisa Matsuda; Hisataka Yasui; Akira Takeshita; Kenji Sunagawa
Journal:  Circulation       Date:  2004-11-01       Impact factor: 29.690

7.  p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload.

Authors:  Masanori Sano; Tohru Minamino; Haruhiro Toko; Hideyuki Miyauchi; Masayuki Orimo; Yingjie Qin; Hiroshi Akazawa; Kaoru Tateno; Yosuke Kayama; Mutsuo Harada; Ippei Shimizu; Takayuki Asahara; Hirofumi Hamada; Shuhei Tomita; Jeffrey D Molkentin; Yunzeng Zou; Issei Komuro
Journal:  Nature       Date:  2007-03-04       Impact factor: 49.962

8.  Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor.

Authors:  Hon-Kan Yip; Li-Teh Chang; Cheuk-Kwan Sun; Ali A Youssef; Jiunn-Jye Sheu; Ching-Jen Wang
Journal:  Circ J       Date:  2008-01       Impact factor: 2.993

9.  The "no-reflow" phenomenon after temporary coronary occlusion in the dog.

Authors:  R A Kloner; C E Ganote; R B Jennings
Journal:  J Clin Invest       Date:  1974-12       Impact factor: 14.808

10.  Extracorporeal shock wave therapy reverses ischemia-related left ventricular dysfunction and remodeling: molecular-cellular and functional assessment.

Authors:  Morgan Fu; Cheuk-Kwan Sun; Yu-Chun Lin; Ching-Jen Wang; Chiung-Jen Wu; Sheung-Fat Ko; Sarah Chua; Jiunn-Jye Sheu; Chiang-Hua Chiang; Pei-Lin Shao; Steve Leu; Hon-Kan Yip
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

View more
  1 in total

Review 1.  Use of the Shock Wave Therapy in Basic Research and Clinical Applications-From Bench to Bedsite.

Authors:  Piotr Rola; Adrian Włodarczak; Mateusz Barycki; Adrian Doroszko
Journal:  Biomedicines       Date:  2022-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.